In the realm of medical advancements, the treatment of prostate cancer, a significant health concern for middle-aged men, has seen remarkable progress. This article, tailored for students from elementary to high school, aims to educate you on the basics of prostate cancer, new therapies, and ho...
With the support by the National Natural Science Foundation of China and other grants,the laboratory led by Prof.Xu Yong(许永)at Guangzhou Institute of Biomedicine and Health,Chinese Academy of Sciences,reported a new treatment target for prostate cancer,which was published in Nature中国科学基金(...
and approx. 310,000 die from prostate cancer (GLOBOCAN). There was over four times the incidence of prostate cancer in 2017 as in the 1950s, but at the same time, the treatments have been improving, so many more live longer
For the first time, researchers have discovered that prostate cancer can be killed by targeting a single enzyme, called PI5P4Kα. The findings, published recently inScience Advances, could help address the growing threat of treatment resistance in prostate cancer and could also lead to improved t...
CHICAGO, June 4 (Xinhua) -- A combination of two existing prostate cancer therapies could extend lives of men with advanced, high-risk prostate cancer, a study showed. The addition of Zytiga to androgen-deprivation therapy can "significantly" increase overall survival in men with newly diagnosed...
New therapy modalities for the treatment of advanced prostate cancer based on peptide analogues are reviewed. Results Agonists and antagonists of luteinising hormone-releasing hormone (LHRH) lead to androgen deprivation, but direct effects on tumours may also play a role. Radiolabeled somatostatin analog...
“represents a revolution in whole-gland treatment for prostate cancer.” “prostate cancer is the most common form of cancer in men, affecting one in eight men in their lifetime,” he said. “we have more research to do, but if validated, (ultrasound) has the ...
Researchers at the Queen Mary University of London and a team of collaborators have identified a genetic signature among prostate tumors that may help determine the best course of treatment for patients. The results of the study will be published in the March 2011 issue of Lancet Oncology. Scient...
doi:10.1038/nrurol.2013.232Grivas, Petros D.Keller, Evan T.Nature Reviews UrologyPetros D.Grivas, Evan T.Keller. (2013) Prostate cancer: Radium-223: a new treatment option for bone-metastatic CRPC. Nature Reviews Urology 10 , 630-631 /...
A new experimental test may be able to help doctors in the near future to better identify which prostate cancer patients need aggressive treatment. As it stands now, once prostate cancer is diagnosed, there’s really no way to know exactly which cases are life-threatening – and most are not...